Novo's False Ad Suit Against Eli Lilly Ramps Up GLP-1 Rivalry
By Bonnie Eslinger · July 21, 2026, 6:23 PM EDT
Pharmaceutical giant Novo Nordisk Inc. slapped rival Eli Lilly & Co. with a false advertising suit in New Jersey federal court Tuesday, calling a marketing campaign for the rival's weight loss...
To view the full article, register now.